Overexpression of human insulin-like growth factor binding protein-1 in the mouse leads to nephron deficit

Pediatric Research

Volumn 49, Issue 5, 2001, Pages 660-666

  Doublier, S ^a   Amri, K ^a   Seurin, D ^a   Moreau, E ^a   Merlet Benichou, C ^a   Striker, G E ^a   Gilbert, T ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1;

ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; GENE EXPRESSION; KIDNEY DEVELOPMENT; MOUSE; NEPHRON; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENE;

EID: 0035040824     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200105000-00009     Document Type: Article

References (42)

1. Organogenesis of the kidney
2. Fetal nephron mass: Its control and its deficit
3. Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factor
4. Ureteric bud cells secrete multiple factors, including bFGF, which rescue renal progenitors from apoptosis
5. Metanephros organogenesis is highly stimulated by vitamin A derivatives in organ culture
6. Regulation of c-ret expression by retinoic acid in rat metanephros: Implication in nephron mass control
7. Role of retinoids in renal development: Pathophysiological implication
8. A growth deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
9. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
10. The IGFs and their binding proteins in murine development
11. Gene expression of the insulin-like growth factor system during mouse kidney development
12. Insulin-like growth factors I and II are produced in the metanephros and are required for growth and development in vitro
13. Distribution and relevance of insulin-like growth factor-I receptor in metanephric development
14. Liver-specific expression of human insulin-like growth factor binding protein-1 in transgenic mice: Repercussions on reproduction, ante- and perinatal mortality and postnatal growth
15. Defect of nephrogenesis by gentamicin in rat metanephric organ culture
16. Metanephric development in serum free organ culture
17. The effect of intrauterine growth retardation on the development of renal nephrons
18. Human fetal kidney morphometry during gestation and the relationship between weight, kidney morphometry and plasma active renin concentration at birth
19. Intrauterine growth retardation leads to a permanent nephron deficit in the rat
20. Effects of maternal protein restriction on the kidney of the newborn young of rats
21. Insulin-like growth factor binding proteins and their role in controlling IGF actions
22. Expression of insulin-like growth factor and binding protein genes during nephrogenesis
23. Localization of mRNAs for insulin-like growth factor binding proteins 1 to 6 in rat kidney
24. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus: Relationships with growth in normal subjects and in subjects with intrauterine growth retardation
25. Circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) and hepatic mRNA are increased in the small for gestational age (SGA) fetal rat
26. Structure, evolution, expression and regulation of insulin-like growth factors I and II
27. Insulin-like growth factor I regulates renal development in rodents
28. The regulation of growth and intracellular signaling by integrins
29. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence
30. Integrin alpha 8 beta 1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis
31. Integrin a6Bb1 is involved in kidney tubulogenesis in vitro
32. Alpha 3 beta 1 integrin has a crucial role in kidney and lung organogenesis
33. Some pathophysiologic changes in experimental intrauterine malnutrition
34. Effect on the young rat of maternal protein restriction
35. Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring
36. Nephron number: Variability is the rule: Causes and consequences
37. Serum levels of somatomedins and somatomedin-binding protein in pregnant women with type I or gestational diabetes and their infants
38. Placental protein 12 (PP12): A new test for the prediction of the small-for-gestational-age infant
39. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: Relation to fetal weight
40. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: Correlations with birth weight
41. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: Relation to birthweight and maternal weight
42. Insulin-like growth factors (IGFs), IGF binding proteins (IGFBPs) and IGFBP protease in human uterine endometrium: Their potential relevance to endometrial cyclic and maternal-embryonic interactions